|
業務類別
|
-- |
|
業務概覽
|
GlobeImmune Inc is a U.S.-based biopharmaceutical company which focuses on developing products for the treatment of cancer and infectious diseases based on its proprietary Tarmogen platform. It develops few Tarmogen product candidates for infectious disease and multiple cancer indications. The pipeline products of the company are GS-4774, GI-19000, GI-2010, GI-18000 which targets HBV and HIV antigens, TB antigens and Delta virus antigens and Oncology product candidates such as GI-6207, GI-6301, GI4000 which targets Carcinoembryonic antigen, Brachyury, and Mutated Ras. |
| 公司地址
| 1450 Infinite Drive, Louisville, CO, USA, 80027 |
| 電話號碼
| +1 720 667-2300 |
| 傳真號碼
| +1 303 625-2710 |
| 公司網頁
| https://globeimmune.com |
| 員工數量
| 2 |
| Dr. Timothy C. Rodell, PhD. |
Managing Director, President and Chief Executive Officer |
-- |
16/03/2016 |
| Mr. C. Jeffrey Dekker |
Vice President, Finance, Treasurer and Secretary |
-- |
16/03/2016 |
|
|
| Augustine J. Lawlor |
Independent Director |
16/03/2016 |
| Daniel J. Mitchell |
Independent Director |
16/03/2016 |
| Dr. J. William Freytag,PhD |
Chairman of the Board |
16/03/2016 |
| S. Edward Torres |
Independent Director |
16/03/2016 |
| Dr. Timothy C. Rodell, PhD. |
Managing Director, President and Chief Executive Officer |
16/03/2016 |
|
|
|
|
